Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials

Lewy body dementia (LBD), including dementia with Lewy bodies and Parkinson’s disease dementia, affects over a million people in the USA and has a substantial impact on patients, caregivers, and society. Symptomatic treatments for LBD, which can include cognitive, neuropsychiatric, autonomic, sleep,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Res Ther
Autors principals: Goldman, Jennifer G., Forsberg, Leah K., Boeve, Bradley F., Armstrong, Melissa J., Irwin, David J., Ferman, Tanis J., Galasko, Doug, Galvin, James E., Kaufer, Daniel, Leverenz, James, Lippa, Carol F., Marder, Karen, Abler, Victor, Biglan, Kevin, Irizarry, Michael, Keller, Bill, Munsie, Leanne, Nakagawa, Masaki, Taylor, Angela, Graham, Todd
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7597002/
https://ncbi.nlm.nih.gov/pubmed/33121510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-020-00703-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars